- Institution
- 전북특별자치도 전주시
- Department
- 건강증진과
◎암환자 의료비 지원
Programme 암환자 의료비지원사업(전환사업)
Amounts and period
- Budgeted amount
- 610,000,000 KRW
- 전년도예산액
- Present in the source but not extracted
- Change
- Not comparable
Changes are calculated only when both amounts are known in full. No percentage is calculated when the comparison amount is zero.
Programme hierarchy and share
The selected item’s share of each parent budget, calculated from amounts in the same source document.
A share is not calculated for missing or partial amounts, non-positive parent amounts, or an item amount greater than its parent.
-
Department 건강증진과 7,527,809,000 KRW8.1%
-
Policy 질병없는 건강도시 기반구축 6,873,831,000 KRW8.9%
-
Programme 건강지원 2,722,876,000 KRW22.4%
-
Project 암환자 의료비지원사업(전환사업) 610,000,000 KRW100.0%
-
Budget category 민간이전 610,000,000 KRW100.0%
-
Statistical item 의료 및 회복비 610,000,000 KRW100.0%
-
Item ◎암환자 의료비 지원 610,000,000 KRW
- Category–statistical code
- 307-01
- Group
- Not provided in source
Original description
Not provided in source
Institution and programme names are shown as the original Korean source text.
Detailed budget items
1 itemsData source
- Document ID
doc_0k9nt46g3kcqe25rf9y686kb67- Source document status
- Available
- File type
- application/pdf
- File size
- 235.142 KiB
- Location inside the source
- Page 18 Row 12 Line 2 Column level4
Source and reference
FY 2026 release No source record
- Fiscal year of record
- 2026
- Fetched from the source
- 2026-08-09 02:50
- Read and interpreted
- 2026-08-09 02:50
- Query snapshot refreshed
- 2026-09-02 03:23
- Item ID
bi_2yq8wr2m82ccemfvebk0g9psmm- Address of this item
- /en/BudgetDetail/Item/bi_2yq8wr2m82ccemfvebk0g9psmm
Related records
Similar budgets
5 itemsKeyword “암환자” · classification 307-01
- ◎암환자 의료비 지원 610,000,000 KRW
- ○ 암환자 의료비 지원(도 전환) 68,000,000 KRW
- ○ 암환자 의료비 지원 87,480,000 KRW
- ○암환자 의료비 지원경정 60,000,000 KRW +9.2%
- ○암환자 의료비 지원경정 320,000,000 KRW −20.0%
These items were verified within a limited set of name search results.
AI analysis report
AI analysis reports are not yet available.